Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Clinical trial NCT03620019 · COMPLETED

Trial details

NCT number: NCT03620019
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage Iii Melanoma Stage Iv Melanoma Melanoma (Skin)Cutaneous Melanoma

Start date: 2018-09-10
Primary completion: 2023-04-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.